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ABSTRACT
Crack cocaine can cause a variety of pulmonary and
cardiac complications. Pulmonary findings in a 65-
year-old man with non-Hodgkin lymphoma who pre-
sented with shortness of breath not resolving with
antibiotics are presented here. The usual manifesta-
tion of “crack lung” in an unusual clinical circumstance
underlines the importance of a clinical history in such
cases. The finding of “crack lung” preceded the diag-
nosis of probable “crack heart.” No other similar pub-
lished case reports could be identified in the literature.
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1. PRESENTATION
A 65-year-old man with biopsy-proven follicular non-
Hodgkin lymphoma grade 2 was referred for treat-
ment. At initial presentation, he had shortness of breath
on exertion and wheezing. Past medical history in-
cluded idiopathic venous thrombosis in his right arm,
hypertension, and chronic sinusitis. He was a 20-pack-
per-year smoker and a known cocaine abuser. He was
taking amoxicillin, fluticasone propionate nasal spray,
coumadin, and thiazide. He had no known drug aller-
gies, no travel history, and no sick contacts. His chest
radiograph demonstrated interstitial opacifications,
and an axial computed tomography (CT) image of the
thorax (Figure 1) showed bibasilar “ground glass”
opacification with septal thickening.
This patient did not respond to a course of
amoxicillin, and his shortness of breath began to
worsen. Vital signs were normal. Physical exam
demonstrated bilateral wheezing and extensive lym-
phadenopathy in the cervical, suboccipital, poste-
rior cervical, anterior cervical, tonsillar, submental,
supraclavicular, and femoral regions. The initial car-
diac examination revealed normal heart sounds, with
a normal jugular venous pressure, but with 2+ pit-
ting edema bilaterally.
The patient was referred to respirology consulta-
tion for investigation to rule out an opportunistic in-
fection. He missed the appointment with the
respirologist and returned 4 months later to the clinic.
1.1 Investigations
The patient’s complete blood count at the first visit
was completely normal. In addition, electrolytes, liver
enzymes, urea, and creatinine were all within normal
limits. Serology for HIV was negative. Sputum initially
showed heavy growth of normal respiratory flora. No
acid-fast bacilli were seen in the sputum. Bronchos-
copy washings were negative for Gram and fungal
stains. An enhanced CT of the thorax in the lung win-
dow confirmed bibasilar “ground glass” opacifications
with septal thickening. Significant mediastinal lym-
phadenopathy was noted. A cardiac nuclear scan per-
formed at the time revealed normal left ventricular
function with a normal contractile pattern.
1.2 Course Between First and Second Thorax CT
The patient admitted to having a crack cocaine ad-
diction. He had missed his first respirology
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appointment as a result of being referred to an addic-
tion rehabilitation program. He received no treatment
during the 4-month interval following the missed ap-
pointment. He had successfully remained off crack
cocaine during the 4 months.
On repeat CT (Figure 2), the “ground glass” opaci-
fications of 4 months past had almost completely dis-
appeared (during this period, the patient was not
smoking crack cocaine). Complete pulmonary func-
tion testing, including a CO diffusion test, was normal.
This patient unfortunately resumed his crack co-
caine habit. He then developed anasarca. A subse-
quent two-dimensional echocardiogram revealed
global systolic left ventricular dysfunction with an
estimated ejection fraction of 25%–28%, and the pa-
tient was admitted to hospital for treatment of heart
failure.
Previously, this man had been treated with
8 cycles of cyclophosphamide, rituximab, vincristine,
and prednisone with only a partial response. The pres-
ence of active heart failure precluded most forms of
applicable chemotherapy. He is now under re-evalu-
ation for treatment options.
1.3 Diagnosis
A presumptive diagnosis of “crack lung” was made
based on the distinctive pattern seen on thorax CT
(multifocal “ground glass” attenuation associated with
septal thickening) 1. This condition improved with-
out any intervention except cessation of crack co-
caine use.
2. DISCUSSION
In Canada, increasing use of oral crack cocaine is a
relatively neglected public health problem 1. Crack
cocaine is the free base of cocaine hydrochloride. To
obtain the “freebase” form, cocaine is boiled in water
and dried 2. Precipitate is obtained by adding ether or
alcohol 3. The precipitate is then heated to produce
the final form of the drug. The name “crack cocaine”
comes from the characteristic cracking sound that the
precipitate makes when heated.
When crack cocaine is smoked, it enters the pul-
monary circulation and reaches the cerebral circula-
tion within 6 seconds (as compared with 18 seconds
for intravenous cocaine and several minutes for in-
haled powder cocaine) 3. This rapid onset of action,
with its tachyphylaxis effect, eventually requires an
increased dose to achieve the same effect, making
the crack form of cocaine a highly addictive sub-
stance. Because crack cocaine is inhaled, most of its
side effects are cardiopulmonary in nature.
Crack cocaine can produce a variety of pulmo-
nary effects including acute respiratory symptoms,
exacerbation of asthma, thermal airway injury, pneu-
mothorax, and pneumomediastinum, cryptogenic or-
ganizing pneumonia, pulmonary hemorrhage,
non-cardiogenic pulmonary edema, pulmonary in-
filtrates with eosinophilia or interstitial pneumoni-
tis 3,4, and pulmonary infarction from embolus 5.
Pulmonary function, including CO diffusion, does
not seem to be deleteriously affected by the use of
crack cocaine 6.
Our patient presented with dyspnea and the CT
findings described earlier. The differential diagnosis
included Pneumocystis jiroveci, cytomegalovirus,
pulmonary hemorrhage, idiopathic interstitial pneu-
monia, hypersensitivity pneumonitis, and pulmonary
edema.
Although smoking crack cocaine is supposed to
increase susceptibility to pulmonary infection because
of dysfunction of the pulmonary alveolar macro-
phages, a bronchoscopy did not reveal an infectious
cause in our patient. Furthermore, bronchoscopy did
not show any visual evidence of gross pulmonary
hemorrhage. However, clinically unapparent alveo-
lar hemorrhage can occur in healthy individuals who
smoke crack cocaine 7.
The finding of significant left ventricular dysfunc-
tion on echocardiogram was felt to be most likely
attributable to the crack cocaine. Cardiovascular
events associated with crack cocaine include myo-
cardial infarction, myocarditis, dilated cardiomyopa-
thy, heart failure, coronary and peripheral vascular
spasm, dysrhythmia, and sudden cardiac death 8.
Non-cardiogenic pulmonary edema was thought
to be caused by increased alveolar permeability from
exposure to crack cocaine; however, evidence sug-
gests that, as compared with tobacco smokers and
non-crack- and non-tobacco-smoking controls, no
increase in alveolar permeability is evident 9.
Our patient received no chemotherapy agent that
is generally thought to cause cardiac damage, al-
though rituximab has been noted to cause immediate
cardiotoxicity 10 and to occasionally cause delayed
reduction in left ventricular function 11.
Our patient also had no burn marks on his hands,
but in the presence of pulmonary infiltrates, evidence
of burn marks on the hands caused by crack pipes FIGURE 2 Computed tomography image of thorax, February 2006.
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used to smoke the cocaine should provide important
clues to the diagnosis 4.
Crack cocaine abuse is uncharacteristic in the age
group represented by our patient, but nonetheless
should be kept in the differential when the “ground
glass” pattern of opacities with septal thickening is
seen on thorax CT.
3. CONCLUSIONS
“Ground glass” opacities on CT scan of the thorax in
an immunocompromised host is a non-specific find-
ing, with a wide differential; however, the present
report highlights the fact that a careful history can
sometimes provide valuable information to reach the
diagnosis. This particular case also highlights the
potential cardiac toxicity of repeated crack cocaine
use. The increased use of this illegal drug in Cana-
dian cities should alert clinicians to look for such
manifestations in all age groups.
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